CoChat

Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic Syndrome

Open access
Satoh, Noriko, Shimatsu, Akira, Kotani, Kazuhiko, Sakane, Naoki, Yamada, Kazunori, Suganami, Takayoshi, Kuzuya, Hideshi, Ogawa, Yoshihiro · 2007 · Diabetes Care
Cited by 137

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

CETP, cholesteryl ester transfer protein; CRP, C-reactive protein; CVD, cardiovascular disease; EPA, eicosapentaenoic acid; n-3 PUFA, n-3 unsaturated fatty acid; RLP, remnant lipoprotein particle; sdLDL, small dense LDL.A table elsewhere in this issue shows conventional and Syste `me International (SI) units and conversion factors for many substances.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc06-1179

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 11

  1. Mizuguchi K, Yano T, Tanaka Y, Ishibashi M, Masada A, Mizota M, Fukutake K, Saito Y: Mechanism of the lipid-lowering effect of ethyl all-cis-5,8,11,14,17- icosapentaenoate. Eur J Pharmacol 231:121–127, 1993 · DOI
  2. Hirai A, Terano T, Hamazaki T, Sajiki J, Kondo S, Ozawa A, Fujita T, Miyamoto T, Tamura Y, Kumagai A: The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets. Thromb Res 28:285–298, 1982 · DOI
  3. Krauss RM: Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27:1496–1504, 2004 · DOI · Paper page
  4. Wilkinson P, Leach C, Ah-Sing EE, Hussain N, Miller GJ, Millward DJ, Griffin BA: Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis 181:115–124, 2005 · DOI
  5. Matsuzawa Y: Metabolic syndrome: definition and diagnostic criteria in Japan. J Atheroscler Thromb 12:301, 2005 · DOI · Paper page
  6. Bisgaier CL, Minton LL, Essenburg AD, White A, Homan R: Use of fluorescent cholesteryl ester microemulsions in cholesteryl ester transfer protein assays. J Lipid Res 34:1625–1634, 1993 · DOI
  7. Hoefner DM, Hodel SD, O’Brien JF, Branum EL, Sun D, Meissner I, McConnell JP: Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 47:266–274, 2001 · DOI · Paper page
  8. Lee W, Min WK, Chun S, Jang S, Kim JQ, Lee do H, Park JY, Park H, Son JE: Low-density lipoprotein subclass and its correlating factors in diabetics. Clin Biochem 36:657–661, 2003 · DOI
  9. Satoh N, Ogawa Y, Usui T, Tagami T, Kono S, Uesugi H, Sugiyama H, Sugawara A, Yamada K, Shimatsu A, Kuzuya H, Nakao K: Antiatherigenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect. Diabetes Care 26:2493–2499, 2003 · DOI · Paper page
  10. Zhu H, Xia M, Hou M, Tang Z, Li Y, Ma J, Ling W: Ox-LDL plays dual effect in modulating expression of inflammatory molecules through LOX-1 pathway in human umbilical vein endothelial cells. Front Biosci 10:2585–2594, 2005 · DOI
  11. Madsen T, Christensen JH, Blom M, Schmidt EB: The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 89:517–522, 2003 · DOI · Paper page

Cited by

Metadata

Authors
Satoh, N., Shimatsu, A., Kotani, K., Sakane, N., Yamada, K., Suganami, T., Kuzuya, H., & Ogawa, Y.
Venue
Diabetes Care
Published
2007-01-01
Volume
30
Issue
1
Pages
144-146
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2123713555
Cited by
137
References
5
FWCI
5.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.